Flagship Ventures Management as of Sept. 30, 2016
Portfolio Holdings for Flagship Ventures Management
Flagship Ventures Management holds 7 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seres Therapeutics (MCRB) | 42.6 | $156M | 13M | 12.29 | |
| Syros Pharmaceuticals | 18.2 | $67M | 4.8M | 13.87 | |
| Agios Pharmaceuticals (AGIO) | 13.9 | $51M | 965k | 52.82 | |
| Editas Medicine (EDIT) | 12.7 | $47M | 3.5M | 13.48 | |
| Selecta Biosciences | 6.4 | $24M | 1.7M | 14.25 | |
| T2 Biosystems | 4.3 | $16M | 2.2M | 7.24 | |
| Eleven Biotherapeutics | 1.8 | $6.6M | 2.4M | 2.80 |
